-
Radioligand therapy for men with a specific type of prostate cancer can produce positive results but requires full disclosure of the side effects as well.
Medical Mythbusting Commentary for July 11, 2024 Source:Doctors excited about targeted prostate cancer therapy, but can’t prescribe it yet
-
Some physicians advocating renaming low-grade cancers as “not cancer”. I do not think this is the correct path to take. It seems a bit patronizing presume how patients will respond to the news of their diagnosis.
Medical Mythbusting Commentary for January 26, 2024 Source:The Cancer That Doctors Don’t Want to Call Cancer
-
Prostate cancer: New combination therapy could reduce progression risk
Medical Mythbusting Commentary for March 27, 2023 Source:Prostate cancer: New combination therapy could reduce progression risk Reference:TALAPRO-2 Supports First-Line Talazoparib/Enzalutamide in All-Comers With mCRPC
-
New insights into how prostate cancer protects itself from latest therapies after researchers uncover the gene responsible for this resistance while investigating new drug that circumvents these protective mechanisms.
Medical Mythbusting Commentary for November 28, 2022 Source:Drug triggers immune cells to attack prostate cancer Reference:Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance.
-
McGill University study shows that a shortened course of radiation therapy is safe and effective for men with high-risk prostate cancer
Medical Mythbusting Commentary for October 24, 2022 Source:Shortened course of radiation therapy safe and effective for men with high-risk prostate cancer
-
Study will evaluate efficacy and outcomes of new imaging technology surveillance for men with prostate cancer
Health Headlines Commentary for November 1 , 2019 Source:Ontario men to have access to advanced prostate cancer imaging
-
Anecdote and celebrity endorsement should not influence screening test policy
Health Headlines Commentary for May 7, 2018 Source: Canadian coaching legend Brian Kilrea upbeat for prostate cancer fight
-
New prostate screening guidelines possible effect on prostate surgery rates studied
Health Headlines Commentary for November 3, 2016 Source: Prostate Surgery Rates Fall After Screening Advice, Study Finds Reference: National Trends in Prostate Biopsy and Radical Prostatectomy Volumes Following the United States Preventative Services Task Force Guidelines Against Prostate-Specific Antigen Screening
-
10-year outcome similar for monitoring, surgery, or radiotherapy for localized early stage prostate cancer
Health Headlines Commentary for September 15, 2016 Source: Treat or monitor early prostate cancer? 10-year survival same Reference: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer Commentary: Invasive early prostate cancer treatments not always needed